These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia. Beltrán-Camacho L; Rojas-Torres M; Durán-Ruiz MC Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652743 [TBL] [Abstract][Full Text] [Related]
14. Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Raval Z; Losordo DW Circ Res; 2013 Apr; 112(9):1288-302. PubMed ID: 23620237 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review. Attanasio S; Snell J Cardiol Rev; 2009; 17(3):115-20. PubMed ID: 19384084 [TBL] [Abstract][Full Text] [Related]
16. Regenerative medicine in critical limb ischemia. Ohno T; Kaneda H; Nagai Y; Fukushima M J Atheroscler Thromb; 2012; 19(10):883-9. PubMed ID: 22785564 [TBL] [Abstract][Full Text] [Related]
17. Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials. Lakshmanan R; Ukani G; Rishi MT; Maulik N Can J Physiol Pharmacol; 2017 Oct; 95(10):1125-1140. PubMed ID: 28407473 [TBL] [Abstract][Full Text] [Related]
18. The current state of stem cell therapy for peripheral artery disease. Gupta NK; Armstrong EJ; Parikh SA Curr Cardiol Rep; 2014 Feb; 16(2):447. PubMed ID: 24414120 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease. Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991 [TBL] [Abstract][Full Text] [Related]